LOS ANGELES, Nov. 18, 2004 (PRIMEZONE) -- HeartSTAT Technology, Inc. (Pink Sheets:HSTA) announced the signing of an engagement letter under which US EURO Securities, Inc. a private, global investment bank headquartered in Los Angeles, will provide investment banking services for HeartSTAT.
US EURO Securities has been engaged to raise up to $5,000,000 through a private placement of HSTA's securities, allowing the Company to complete its final stage R&D and bring to market the first practical system for monitoring blood flow perfusion (blood oxygen transport) and heart dynamics.
Ted Russell, President and Chief Technical Officer of HeartSTAT, stated, "Our technology for monitoring blood flow perfusion and heart dynamics will fill a very necessary void in the medical technology market. These technologies have long been considered the 'holy grail' of the health care industry due to their non-invasive nature. We're confident our relationship with US EURO Securities will help us achieve completion of the development of this vital technology and introduce it into the market."
Michael Fugler Chairman of US EURO Securities commented, "Our global investment platform fits well with HeartSTAT whose technology has universal appeal. HeartSTAT is positioned to be an important provider of science based, non-invasive medical technology to the health care industry, not only in North America but worldwide because of the preferred use of, and high value placed on, non-invasive methods in other parts of the world such as Europe and Asia."
About HeartSTAT Technology, Inc.
HeartSTAT plans to bring to market the first practical system for monitoring blood flow perfusion (blood oxygen transport) and heart dynamics. The system is for revealing vital patient problems that alter blood flow while BP does not change, to enable providing earlier and more specific intervention than is presently possible. This system can also provide real time monitoring of heart loads and cardiovascular biophysics, which may later open up a large internet-based physician market for managing cardiovascular disease, drug interaction, heart attacks and heart failure. See our website at www.HeartSTAT.com.
About US EURO Securities, Inc.
US EURO Securities, Inc. is a private, global investment bank headquartered in Los Angeles, California providing global financial solutions. The firm has a team of experienced financial professionals throughout the United States, Europe and Asia and is focused on providing a wide range of financial advisory services, including equity and debt financing, mergers and acquisitions as well as domestic and international business development for a select clientele of international institutions, domestic and international corporations and high net worth individuals. See our website at www.useurosecurities.com.
Statements in this release are made pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties including, without limitation, continued acceptance of the Company's services, increased levels of competition for the Company and dependence on the performance of the Management of the Company